Cargando…

Clinical relevance of circulating angiogenic cells in patients with ischemic stroke

BACKGROUND: Endothelial progenitor cells (EPCs) are circulating angiogenic cells with endothelial features associated with risk for stroke. We aimed to delve into their functional characteristics. EPCs were isolated and cultured from Ischemic Stroke (IS) patients and predictors of their variance eva...

Descripción completa

Detalles Bibliográficos
Autores principales: Rodríguez-Esparragón, Francisco, Torres-Mata, Laura B., López-Fernández, Juan Carlos, Cappiello, Laura, González-Martín, Jesús M., Clavo, Bernardino, Serna-Gómez, Jaime A., Estupiñán-Quintana, Lidia, Torres-Ascensión, Cristina, Villar, Jesús
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939119/
https://www.ncbi.nlm.nih.gov/pubmed/35313809
http://dx.doi.org/10.1186/s12872-021-02421-8
_version_ 1784672678765920256
author Rodríguez-Esparragón, Francisco
Torres-Mata, Laura B.
López-Fernández, Juan Carlos
Cappiello, Laura
González-Martín, Jesús M.
Clavo, Bernardino
Serna-Gómez, Jaime A.
Estupiñán-Quintana, Lidia
Torres-Ascensión, Cristina
Villar, Jesús
author_facet Rodríguez-Esparragón, Francisco
Torres-Mata, Laura B.
López-Fernández, Juan Carlos
Cappiello, Laura
González-Martín, Jesús M.
Clavo, Bernardino
Serna-Gómez, Jaime A.
Estupiñán-Quintana, Lidia
Torres-Ascensión, Cristina
Villar, Jesús
author_sort Rodríguez-Esparragón, Francisco
collection PubMed
description BACKGROUND: Endothelial progenitor cells (EPCs) are circulating angiogenic cells with endothelial features associated with risk for stroke. We aimed to delve into their functional characteristics. EPCs were isolated and cultured from Ischemic Stroke (IS) patients and predictors of their variance evaluated. METHODS: This is a single-center observational study evaluating 187 consecutively hospitalized patients with IS. EPCs were isolated from blood samples. The number of circulating angiogenic cells (CACs), colony-forming units (CFU-ECs) and the emergence of late outgrowths endothelial cells (LOECs) were counted. We collected clinical variables and measured the stromal cell-derived factor 1 alpha (SDF1α) serum levels. We also examined the relative telomere length and the expression of osteogenic gene markers in CACs. RESULTS: CACs counts and CFU-ECs colony numbers were positively correlated (rho = 0.41, p < 0.001, n = 187). We found significant differences according to whether thrombolytic treatment was performed in the distribution of CFU-ECs (odds ratio (OR) = 2.5; 95% confidence interval (CI) 1.01–6.35; p = 0.042) and CACs (OR = 4.45; 95% IC 1.2–15.5; p = 0.012). The main determinants of CACs variation were the number of risks factors, thrombolysis treatment, arterial hypertension, LOECs occurrence, and the vascular endothelial growth factor expression, whereas CFU-ECs variations depended on hemoglobin content and the relative reduction in the National Institutes of Health Stroke Scale (NIHSS) criteria. The main predictors of LOECs appearance were thrombolysis and length of hospital stay. CONCLUSIONS: Our study supports the relevance of patient risk factors and treatments in the analysis of the functional properties of EPCs.
format Online
Article
Text
id pubmed-8939119
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-89391192022-03-23 Clinical relevance of circulating angiogenic cells in patients with ischemic stroke Rodríguez-Esparragón, Francisco Torres-Mata, Laura B. López-Fernández, Juan Carlos Cappiello, Laura González-Martín, Jesús M. Clavo, Bernardino Serna-Gómez, Jaime A. Estupiñán-Quintana, Lidia Torres-Ascensión, Cristina Villar, Jesús BMC Cardiovasc Disord Research Article BACKGROUND: Endothelial progenitor cells (EPCs) are circulating angiogenic cells with endothelial features associated with risk for stroke. We aimed to delve into their functional characteristics. EPCs were isolated and cultured from Ischemic Stroke (IS) patients and predictors of their variance evaluated. METHODS: This is a single-center observational study evaluating 187 consecutively hospitalized patients with IS. EPCs were isolated from blood samples. The number of circulating angiogenic cells (CACs), colony-forming units (CFU-ECs) and the emergence of late outgrowths endothelial cells (LOECs) were counted. We collected clinical variables and measured the stromal cell-derived factor 1 alpha (SDF1α) serum levels. We also examined the relative telomere length and the expression of osteogenic gene markers in CACs. RESULTS: CACs counts and CFU-ECs colony numbers were positively correlated (rho = 0.41, p < 0.001, n = 187). We found significant differences according to whether thrombolytic treatment was performed in the distribution of CFU-ECs (odds ratio (OR) = 2.5; 95% confidence interval (CI) 1.01–6.35; p = 0.042) and CACs (OR = 4.45; 95% IC 1.2–15.5; p = 0.012). The main determinants of CACs variation were the number of risks factors, thrombolysis treatment, arterial hypertension, LOECs occurrence, and the vascular endothelial growth factor expression, whereas CFU-ECs variations depended on hemoglobin content and the relative reduction in the National Institutes of Health Stroke Scale (NIHSS) criteria. The main predictors of LOECs appearance were thrombolysis and length of hospital stay. CONCLUSIONS: Our study supports the relevance of patient risk factors and treatments in the analysis of the functional properties of EPCs. BioMed Central 2022-03-21 /pmc/articles/PMC8939119/ /pubmed/35313809 http://dx.doi.org/10.1186/s12872-021-02421-8 Text en © The Author(s) 2022 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research Article
Rodríguez-Esparragón, Francisco
Torres-Mata, Laura B.
López-Fernández, Juan Carlos
Cappiello, Laura
González-Martín, Jesús M.
Clavo, Bernardino
Serna-Gómez, Jaime A.
Estupiñán-Quintana, Lidia
Torres-Ascensión, Cristina
Villar, Jesús
Clinical relevance of circulating angiogenic cells in patients with ischemic stroke
title Clinical relevance of circulating angiogenic cells in patients with ischemic stroke
title_full Clinical relevance of circulating angiogenic cells in patients with ischemic stroke
title_fullStr Clinical relevance of circulating angiogenic cells in patients with ischemic stroke
title_full_unstemmed Clinical relevance of circulating angiogenic cells in patients with ischemic stroke
title_short Clinical relevance of circulating angiogenic cells in patients with ischemic stroke
title_sort clinical relevance of circulating angiogenic cells in patients with ischemic stroke
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8939119/
https://www.ncbi.nlm.nih.gov/pubmed/35313809
http://dx.doi.org/10.1186/s12872-021-02421-8
work_keys_str_mv AT rodriguezesparragonfrancisco clinicalrelevanceofcirculatingangiogeniccellsinpatientswithischemicstroke
AT torresmatalaurab clinicalrelevanceofcirculatingangiogeniccellsinpatientswithischemicstroke
AT lopezfernandezjuancarlos clinicalrelevanceofcirculatingangiogeniccellsinpatientswithischemicstroke
AT cappiellolaura clinicalrelevanceofcirculatingangiogeniccellsinpatientswithischemicstroke
AT gonzalezmartinjesusm clinicalrelevanceofcirculatingangiogeniccellsinpatientswithischemicstroke
AT clavobernardino clinicalrelevanceofcirculatingangiogeniccellsinpatientswithischemicstroke
AT sernagomezjaimea clinicalrelevanceofcirculatingangiogeniccellsinpatientswithischemicstroke
AT estupinanquintanalidia clinicalrelevanceofcirculatingangiogeniccellsinpatientswithischemicstroke
AT torresascensioncristina clinicalrelevanceofcirculatingangiogeniccellsinpatientswithischemicstroke
AT villarjesus clinicalrelevanceofcirculatingangiogeniccellsinpatientswithischemicstroke